MEDS

NASDAQ open

DataMEDS AI

6.26 USD
+4.64+286.42%
盘后 0.90 0.00%
2026-09-16
市值
$18.59M
市盈率
EPS
-43.73
股息率
52 周区间
0.82 – 75.00
成交量
183.60M
Beta
2.17
目标价
52W 低 0.8252W 高 75.00
价格走势

公司简介

DataMEDS AI, Inc. operates as a health IT company in the United States. The company focuses on the vertical integration of technology, pharmacy, pharmaceutical-adjacent, and telemedicine business units to deliver an enhanced healthcare experience for consumers. It offers tools, such as the EinsteinRx, a pharmacy dispensing AI platform; the PharmacyChain, a smart contracts platform; Patient Rx Adherence Tool; and HubRx AI. It also operates as a pharmacy distributor; and provides clinical concierge services, . The company was formerly known as We...

关联新闻

  • This AI stock experienced a 5x rally on Wednesday

    DataMeds AI (MEDS) shares ripped higher on Wednesday morning as the company completed its acquisition of Helomics AI cancer diagnostics laboratory and precision oncology contract research organization...

    Invezz2026-09-16MEDS